Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin
- 1 July 1996
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 271 (1), C304-C311
- https://doi.org/10.1152/ajpcell.1996.271.1.c304
Abstract
We show that bryostatin 1 (Bryo) rapidly produces an inactive, incompetent 76-kDa form of protein kinase C-alpha (PKC-alpha) in the LLC-MK2 line of renal epithelial cells. Bryo, like phorbol 12-myristate 13-acetate (PMA), acutely activated PKC, as indicated by autophosphorylation and translocation of PKC-alpha, the predominant PMA-sensitive isoform expressed by the cells. Bryo concomitantly increased the 32P labeling of 80-kDa PKC-alpha by autophosphorylation and produced a 76-kDa form of PKC-alpha that lacked detectable 32P. The 76-kDa form was in the particulate rather than the cytosolic fraction, which suggests that it was produced from activated kinase. Alkaline phosphatase treatment of immunoprecipitated PKC-alpha converted the 80-kDa form to 76 kDa, but it had no effect on the mobility of the 76-kDa form, suggesting that it was not phosphorylated. Pulse-chase labeling of PKC-alpha with [35S]Met/Cys indicated that there is a precursor-product relationship between the 80- and 76-kDa forms, respectively. Inhibition of protein synthesis had no effect on the production of 76-kDa PKC-alpha by Bryo. PMA also produced 76-kDa PKC-alpha but was less potent and efficacious than Bryo. Bryo produced a more rapid loss of 80-kDa PKC-alpha protein and total Ca(2+)- and phospholipid-dependent PKC activity than PMA. The 76-kDa form is inactive and incompetent because it lacked detectable 32P under conditions that strongly autophosphorylated the 80-kDa form. We suggest that dephosphorylation predisposes PKC to proteolysis, and greater production of the 76-kDa form explains the more efficient downregulation of the kinase by Bryo vs. PMA.Keywords
This publication has 19 references indexed in Scilit:
- Protein Kinase C (PKC)-induced PKC Down-regulationPublished by Elsevier ,1995
- Protein kinase C V3 domain mutants with differential sensitivities to m‐calpain are not resistant to phorbol‐ester‐induced down‐regulationEuropean Journal of Biochemistry, 1994
- Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor Induction In VivoJNCI Journal of the National Cancer Institute, 1993
- Protein Kinase C-α But Not Protein Kinase C-ϵ Is Differentially Down-Regulated by Bryostatin 1 and Tetradecanoyl Phorbol 13-Acetate in SH-SY5Y Human Neuroblastoma CellsBiochemical and Biophysical Research Communications, 1993
- Bryostatins mimic the effects of phorbol esters in intact human plateletsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skinCarcinogenesis: Integrative Cancer Research, 1987
- The Complete Primary Structure of Protein Kinase C—the Major Phorbol Ester ReceptorScience, 1986
- Bryostatins: Potent, new mitogens that mimic phorbol ester tumor promotersBiochemical and Biophysical Research Communications, 1985
- Isolation and structure of bryostatin 1Journal of the American Chemical Society, 1982
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970